Smartphone-Administered App Treatment for Adults With Body Dysmorphic Disorder
Completed · Not applicable
Conditions studied: Body Dysmorphic Disorders
In brief
The investigators are developing and testing a Smartphone-based cognitive behavioral therapy (CBT) "app" for body dysmorphic disorder (BDD). The investigators hypothesize that app-based CBT for BDD will be feasible and acceptable to individuals with BDD, and will improve body image concerns and related outcomes.
Key facts
- Study ID
- NCT03221738
- Run by
- Massachusetts General Hospital
- People needed
- 10
- Starts
- 2017-07-24
- Expected to finish
- 2019-01-18
- Last updated by the study team
- 2019-06-26
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- At least 18 years of age
- Outpatients
- Meets current diagnosis of primary DSM-5 BDD
- Has score on BDD-YBOCS of ≥ 20
- Currently living in the United States
You may not qualify if…
- Psychotropic medication changes within 2 months prior to enrollment
- Participants taking psychotropic medication have to have been on a stable dose for at least 2 months prior to enrollment and not change medication during study period
- Participated in CBT for BDD ever during lifetime
- Current substance dependence
- Lifetime bipolar disorder or psychosis
- Acute, active suicidal ideation
- Current severe comorbid major depression, defined by a PHQ-9 total score ≥ 20
- Personality disorder that could jeopardize treatment participation (e.g., borderline personality disorder with self-harm)
- Concurrent psychological treatment
- Do not own a supported mobile Smart phone with a data plan (currently iPhone 5S or more recent, running iOS 9 or newer)
- Intellectual disability or other cognitive impairment that would interfere with ability to engage in CBT
Where it is running
- Massachusetts General Hospital — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.